Log In
Print this Print this


  Manage Alerts
Collapse Summary General Information
Company Bioniz Therapeutics Inc.
DescriptionSelective inhibitor of interleukin-2 (IL-2), IL-9 and IL-15
Molecular Target Interleukin-2 (IL-2) ; Interleukin-9 (IL-9)
Mechanism of Action 
Therapeutic ModalityPeptide

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today